Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering skin disease and is characterized by the presence of autoantibodies directed against the hemidesmosomal proteins BP180 and BP230 that can be detected in the skin and serum of BP patients. Histologically, the dermal infiltration of eosinophils is obvious. The objective of this review is to present evidence that eosinophils play a key role in the pathogenesis of BP. Eosinophils, together with cytokines and chemokines regulating their production, recruitment and activation, are abundantly present in lesional skin, in blisters and in peripheral blood of patients with BP.
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Eosinophils: multifaceted immune cells
Despite the fact that the skin is normally devoid of eosinophils, eosinophil infiltration can be found in a broad spectrum of infectious, allergic, autoimmune, and neoplastic skin diseases (6). So far, information about a direct pathogenic role of eosinophils in skin diseases is scarce; indeed most knowledge about eosinophil function has been generated in the context of parasitic infections, bronchial asthma and hypereosinophilic syndromes. Blood eosinophilia derives from either mutations or gene fusions in the genome of the eosinophils (intrinsic eosinophilia) or increased production and release of cytokines affecting eosinophils by inflammatory or tumor cells (extrinsic eosinophilia) (7) . Eosinophils are generated in and differentiate in the bone marrow from where they are released into the circulation. In the peripheral blood, they represent 1% to 5% of the leukocytes under physiologic conditions (8) .
Interleukin (IL)-3, IL-5, and GM-CSF represent eosinophil hematopoietins regulating the production, differentiation, activation, trafficking, and survival of eosinophils (9, 10) .
Eosinophils are innate immune cells. Their primary function has been related to host defense, in particular, the protection against helminth parasites (11) . By generating extracellular DNA nets associated with toxic granule proteins, the so called eosinophil extracellular traps (EETs), eosinophils have been shown to bind and kill bacteria (12, 13) . On the other hand, the toxic granule proteins normally released to defend against infections, also cause tissue damage (11, 14) . Although eosinophils expressing MHC class II can serve as antigen presenting cells, they are relatively inefficient when compared to dendritic cells or other professional antigenpresenting cells (15) . In addition, eosinophils play an important role in repair and remodeling processes as well as in immunomodulation (16, 17) . For instance, eosinophils contribute to tissue fibrosis and remodeling since they express mediators such as fibroblast growth factor (FGF)-2, IL-4, IL-6, IL-11, IL-13, IL-17, IL-25, TGF-β, nerve growth factor (NGF), matrix metalloproteinase (MMP)-9 and vascular endothelial growth factor (VEGF) (18, 19) . By producing the proliferation-inducing 
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Eotaxin that was strongly expressed by the keratinocytes around blisters, was detected at high levels in blister fluids correlating with the number of tissue eosinophils (56) . Moreover, blister fluids contain high amounts of Th2 cytokines including IL-5 (57) (Figure 1 ).
Peripheral blood eosinophilia is a common finding in BP and may range from 5 to 43% (58) . In BP patients, the levels of ECP and MPO were increased compared to controls and decreased upon immunosuppressive therapy (59) Gelatinase-deficient mice were resistant to the blistering effect of passively transfected anti-mBP180 antibodies (69). In an ex vivo BP model, the inhibition of leukocyte elastase and MMP-9 resulted in a suppression of blistering (70).
Eosinophils and experimental BP models
Upon injection of blister fluid of BP patients in the skin of a guinea pig, a mixed dermal infiltration containing mainly neutrophils, but also eosinophils, has been reported (71) . In SCID mice with engrafted human skin, the subcutaneous injection of an anti-basement membrane zone antibody led to an infiltration of eosinophils and
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histologically evident subepidermal blister formation (72) . Similarly, a mixed skin infiltrate composed of eosinophils, neutrophils and mast cells was observed in human skin grafted to nu/nu mice upon receiving IgE antibodies isolated from BP sera (73) . The importance of neutrophils and neutrophil elastase in inducing subepithelial blister formation has been shown in various models of BP (74) (75) (76) . The recruitment of neutrophils to the tissue depended on mast cell activation and degranulation following stimulation by macrophages (77) (78) (79) . The function of antimBP180 IgG was mediated by its Fc domain, whereas the F(ab') 2 of IgG had no substantial pathogenic activity (79, 80) . Fc gamma receptors II, III and IV have been reported to be involved in BP (81, 82) . Complement has been demonstrated to be necessary for blister formation in a mouse model, but was not essential in an ex vivo cryosection model of BP (79, 83) . As shown for neutrophils, the generation of reactive oxygen species was a prerequisite for subepithelial blistering (76) .
The controversy about eosinophils and IgE in BP
In a subgroup of BP patients, both tissue bound and circulating IgE autoantibodies directed to BP antigens can be detected and their presence correlated with disease severity (84-86). As mentioned above, when an IgE hybridoma to LABD97, a component of the shed ectodomain of bullous pemphigoid antigen 2, or IgE from BP patients were injected in animal BP models, erythema and intense scratching as well as eosinophil infiltration and degranulation of mast cells were observed in histology (72, 73) . In humans, IgE anti-BP230 autoantibody levels showed a strong association with local eosinophil accumulation (45). However, it seems unlikely that eosinophils directly interact with IgE, since they lack functionally active high-affinity IgE receptors (FcεRI) (87, 88) . In fact, BP antigen-specific degranulation of basophils and/or mast cells rather than eosinophils has been suggested as a mechanism by which IgE may contribute to lesion development (89) . Recently, minimal expression of the FcεRI alpha-chain on eosinophils of BP patients has been shown, however, a functionality of the receptor has not been demonstrated (90) . Moreover, the same authors reported that IgE to BP antigens did not mediate either eosinophil degranulation or eosinophil localization to the dermal-epidermal junction (65).
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significantly increased as compared to the general population (94, 95) . Thus, there is an urgent need for effective, well-tolerated and safe therapeutic tools for BP patients.
The anti-IL-5 antibodies mepolizumab and reslizumab have demonstrated efficacy and safety in patients with allergic diseases and extrinsic hypereosinophilic syndromes (96) . Moreover, blocking the IL-5 receptor led to a reduction of blood, bone marrow, and tissue eosinophilia in asthma patients (9) . Based on the knowledge that IL-5 specifically regulates eosinophil production, activation and survival and on the observations that IL-5 is increased in the skin, blister fluids and 
